InvestorsHub Logo
Followers 10
Posts 1984
Boards Moderated 0
Alias Born 01/26/2015

Re: None

Tuesday, 12/21/2021 12:19:45 PM

Tuesday, December 21, 2021 12:19:45 PM

Post# of 406738
Nice: Item 1.01 Entry Into A Material Definitive Agreement
On December 6, 2021, Elite Pharmaceuticals Inc. ("Elite”) signed a License and Distribution Agreement with Dexcel Ltd. (Or Akiva, Israel) to be the exclusive distributor of Elite’s generic version of Adderall® for Israel.
Elite’s generic version of Adderall® is an immediate-release mixed salt of a single entity Amphetamine product (Dextroamphetamine Saccharate, Amphetamine Aspartate,
Dextroamphetamine Sulfate, Amphetamine Sulfate). Adderall® is a central nervous system (CNS) stimulant, indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and Narcolepsy. Dexcel will market the 10 mg, 20 mg, and 30 mg tablet
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News